Biodistribution of technetium-99m pertechnetate after Roux-en-Y gastric bypass (Capella technique) in rats

Acta Cir Bras. 2010 Feb;25(1):9-12. doi: 10.1590/s0102-86502010000100004.

Abstract

Purpose: The biodistribution of sodium pertechnetate, the most used radiopharmaceutical in nuclear medicine, has not been studied in details after bariatric surgery. The objective was to investigate the effect of Roux-en-Y gastric bypass (RYGB) on biodistribution of sodium pertechnetate (Na(99m)Tc(-)) in organs and tissues of rats.

Methods: Twelve rats were randomly divided into two groups of 6 animals each. The RYGB group rats were submitted to the Roux-en-Y gastric bypass and the control group rats were not operated. After 15 days, all rats were injected with 0.1 mL of Na(99m)Tc(-) via orbital plexus with average radioactivity of 0.66 MBq. After 30 minutes, liver, stomach, thyroid, heart, lung, kidney and femur samples were harvested, weighed and percentage of radioactivity per gram (%ATI/g) of each organ was determined by gama counter Wizard Perkin-Elmer. We applied the Student t test for statistical analysis, considering p<0.05 as significant.

Results: Significant reduction in mean %ATI/g was observed in the liver, stomach and femur in the RYGB group animals, compared with the control group rats (p<0.05). In other organs no significant difference in %ATI/g was observed between the two groups.

Conclusion: This work contributes to the knowledge that the bariatric surgery RYGB modifies the pattern of biodistribution of Na(99m)Tc(-).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Femur / metabolism
  • Gastric Bypass / adverse effects*
  • Gastric Bypass / methods
  • Gastric Mucosa / metabolism
  • Liver / metabolism
  • Models, Animal
  • Radiopharmaceuticals / pharmacokinetics*
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Sodium Pertechnetate Tc 99m / pharmacokinetics*
  • Tissue Distribution

Substances

  • Radiopharmaceuticals
  • Sodium Pertechnetate Tc 99m